Results 91 to 100 of about 1,188,382 (179)

Harnessing Natural Killer Cells: From Neuroimmunology to Novel Therapies for Central Nervous System Diseases

open access: yesMedComm, Volume 7, Issue 10, October 2026.
This review delineates the multifaceted roles of natural killer (NK) cells in the central nervous system, spanning direct cytolysis, immunoregulation, and crosstalk with the brain microenvironment. We evaluate the translational potential and challenges of NK cell immunotherapies for a spectrum of neurological conditions.
Kaihang Deng, Wai Po Chong
wiley   +1 more source

Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome

open access: yes, 1997
The relative efficacy of plasma exchange (PE) and intravenous immunoglobulin (IVIg) for the treatment of Guillain-Barré syndrome has not been established.
Plasma exchange/Sandoglobulin Guillin-Barré syndrome trial group   +2 more
core   +1 more source

Host Factors Determine Anti-GM1 Response Following Oral Challenge of Chickens with Guillain-Barre Syndrome Derived Campylobacter jejuni Strain GB11 [PDF]

open access: yes, 2010
Background: Anti-ganglioside antibodies with a pathogenic potential are present in C. jejuni-associated Guillain-Barre syndrome (GBS) patients and are probably induced by molecular mimicry.
Dijkstra, J.R. (Jeroen)   +50 more
core   +3 more sources

Development of recurrent facial palsy during plasmapheresis in Guillain-Barré syndrome: a case report

open access: yesJournal of Medical Case Reports, 2010
Introduction Guillain-Barré syndrome is an immune-mediated polyneuropathy that is routinely initially treated with either intravenous immunoglobulin or plasmapheresis.
Weimer Louis H   +2 more
doaj   +1 more source

Fatal recurrent Guillain–Barré syndrome (GBS) in an Ethiopian male: a case report

open access: yesJournal of Medical Case Reports
Introduction Guillain–Barré syndrome (GBS) is a disease affecting the peripheral nerves, leading to a constellation of motor, sensory, and autonomic symptoms.
Eden Tesfaye Beyene   +3 more
doaj   +1 more source

Brucellosis, presenting with guillain-barré syndrome

open access: yes, 2011
Brucellosis is an infectious disease caused by gram-negative bacteria of the genus Brucella. Involvement of the gastrointestinal, hepatobilliary, and skeletal systems has been reported frequently in the literature.
Abdolreza Babamahmoodi   +1 more
core   +1 more source

Podiatric implications of Guillain-Barré syndrome sequelae: a systematic review

open access: yes
Introducción: El síndrome de Guillain-Barré es una polineuropatía inflamatoria aguda de origen autoinmune, caracterizada por debilidad muscular ascendente y compromiso sensitivo.
Rayo Pérez, Ana María   +3 more
core   +1 more source

What is Guillain-Barré Syndrome?

open access: yes
Have you ever gone to get a vaccine and been asked if you have ever had Guillain-Barré syndrome? Guillain-Barré is a disease that affects parts of the nervous system, and it is triggered by the immune system. Because vaccines stimulate the immune system,
Aleya Monsalve, Amin Shah
core   +1 more source

An Update in Guillain-Barré Syndrome

open access: yes, 2020
Guillain-Barré syndrome (GBS) was first described in ...
J B Winer
core  

Síndrome de guillain-barré pós cirurgia bariátrica: relato de caso e revisão de literatura [PDF]

open access: yes, 2020
Guillain-Barré Syndrome is an inflammatory polyneuroradiculopathy, being the most prevalent cause of acute flaccid paralysis, with an annual incidence of 1 to 2 cases per 100,000 people per year. It is clinically characterized, in its most common form,
Rodrigues, Helder Barbosa
core  

Home - About - Disclaimer - Privacy